Daniela Zackova

12PUBLICATIONS
52CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersEpidemiological modellingCellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 30, 2026
Association between proton pump inhibitor co-medication and treatment switching in dasatinib-treated patients with chronic myeloid leukemia: a German real-world evidence study.

|Feb 27, 2025
Total psoriasis regression in a patient with chronic myeloid leukemia treated using nilotinib.

Tomáš Horňák, Daniela Žáčková, Jiří Mayer

|Jan 28, 2025
Clinical and Prognostic Significance of Additional Chromosomal Abnormalities at Diagnosis of Chronic Myeloid Leukemia.

Jiří Mayer, Petra Čičátková, Lenka Kováčová

|Sep 13, 2024
Clinical efficacy and safety of first-line nilotinib or imatinib therapy in patients with chronic myeloid leukemia-Nationwide real life data.

Petra Belohlavkova, Daniela Zackova, Hana Klamova

|Jul 10, 2024
Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial.

Fabio Efficace, Francois-Xavier Mahon, Johan Richter

|Mar 06, 2024
Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes.

Maria Agustina Perusini, Daniela Žáčková, Taehyung Kim

Pageof 2

Frequent Collaborators

5 joint publications

Jiri Mayer

3 joint publications

Tomas Hornak

3 joint publications

Ivana Jeziskova

3 joint publications

Petra Belohlavkova